Chamandi S Dampalla

6PUBLICATIONS
10CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2024
Structure-Guided Design of Potent Coronavirus Inhibitors with a 2-Pyrrolidone Scaffold: Biochemical, Crystallographic, and Virological Studies.

Chamandi S Dampalla, Yunjeong Kim, Alexandria Zabiegala

|Jan 19, 2023
Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies.

Chamandi S Dampalla, Harry Nhat Nguyen, Athri D Rathnayake

|May 31, 2022
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease.

Chamandi S Dampalla, Athri D Rathnayake, Anushka C Galasiti Kankanamalage

|Dec 06, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies.

Chamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera

|Jul 02, 2021
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.

Chamandi S Dampalla, Yunjeong Kim, Naemi Bickmeier

|Jul 02, 2021
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.

Chamandi S Dampalla, Jian Zheng, Krishani Dinali Perera

Pageof 1